Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome

EBioMedicine. 2020 Nov:61:103048. doi: 10.1016/j.ebiom.2020.103048. Epub 2020 Oct 8.

Abstract

Background: Microbial communities and their metabolic components in the gut are of vital importance for immune homeostasis and have an influence on the susceptibility of the host to a number of immune-mediated diseases like acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, little is known about the functional connections between microbiome and metabolome in aGVHD due to the complexity of the gastrointestinal environment.

Method: Initially, gut microbiota and fecal metabolic phenotype in aGVHD murine models were unleashed by performing 16S ribosomal DNA gene sequencing and ultra-high-performance liquid chromatography-mass spectrometry (UHPLC-MS)-based metabolomics.

Findings: The group with aGVHD experienced a significant drop in Lachnospiraceae_unclassified but an increase in the relative abundance of Clostridium XI, Clostridium XIVa and Enterococcus. Meanwhile, a lower content of tyrosine was observed in the gut of aGVHD mice. The correlation analysis revealed that tyrosine-related metabolites were inversely correlated with Clostridium XIVa, besides, Blautia and Enterococcus also displayed the negative tendency in aGVHD condition. Apart from exploring the importance and function of tyrosine, different tyrosine diets were offered to mice during transplantation. Additional tyrosine supplements can improve overall survival, ameliorate symptoms at the early stage of aGVHD and change the structure and composition of gut microbiota and fecal metabolic phenotype. In addition, aGVHD mice deprived from tyrosine displayed worse manifestations than the vehicle diet group.

Interpretation: The results demonstrated the roles and mechanisms of gut microbiota, indispensable metabolites and tyrosine in the progression of aGVHD, which can be an underlying biomarker for aGVHD diagnosis and treatment.

Funding: This research was funded by the International Cooperation and Exchange Program (81520108002), the National Key R&D Program of China, Stem Cell and Translation Research (2018YFA0109300), National Natural Science Foundation of China (81670169, 81670148, 81870080 and 91949115) and Natural Science Foundation of Zhejiang Province (LQ19H080006).

Keywords: Correlation network; Gut microbiome; Metabolomics; Tyrosine; aGVHD.

MeSH terms

  • Acute Disease
  • Animals
  • Biodiversity
  • Chromatography, High Pressure Liquid
  • Computational Biology / methods
  • Dietary Supplements*
  • Disease Management
  • Disease Models, Animal
  • Disease Susceptibility
  • Gastrointestinal Microbiome*
  • Graft vs Host Disease / diagnosis
  • Graft vs Host Disease / etiology*
  • Graft vs Host Disease / metabolism*
  • Graft vs Host Disease / therapy
  • Intestinal Mucosa
  • Mass Spectrometry / methods
  • Metabolome*
  • Metabolomics / methods
  • Metagenomics / methods
  • Mice
  • Phenotype
  • RNA, Ribosomal, 16S / genetics
  • Tyrosine / administration & dosage*

Substances

  • RNA, Ribosomal, 16S
  • Tyrosine